Similar articles

• Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.

  Barton DP, Blanchard DK, Duan C, Roberts WS, Cavanagh D, DeCesare S, Djeu JY. Barton DP, et al. J Soc Gynecol Investig. 1995 Nov-Dec;2(6):762-71. J Soc Gynecol Investig. 1995. PMID: 9420887
• Lymphokine-activated killer cells/tumor-infiltrating lymphocytes therapy: efficacy, toxicity, controversies.

  Dutcher JP. Dutcher JP. J Clin Apher. 1990;5(2):80-2. J Clin Apher. 1990. PMID: 2404970 Review. No abstract available.
• In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.

  Rivoltini L, Gambacorti-Passerini C, Squadrelli-Saraceno M, Grosso MI, Cantù G, Molinari R, Orazi A, Parmiani G. Rivoltini L, et al. Cancer Res. 1990 Sep 1;50(17):5551-7. Cancer Res. 1990. PMID: 2386961
• 15-Deoxyspergualin produces inhibition of lymphokine-activated killer cell activity.

  Thomas F, Matthews C, Pittman K, Thomas J. Thomas F, et al. Transplant Proc. 1992 Apr;24(2):712-3. Transplant Proc. 1992. PMID: 1566494 No abstract available.
• Lymphokine-activated killer lymphocytes: evidence for regulation of induction and function by multiple cytokines.

  Owen-Schaub LB, Grimm EA. Owen-Schaub LB, et al. Immunol Ser. 1989;48:19-35. Immunol Ser. 1989. PMID: 2488321 Review. No abstract available.